Search

Frankie L. Stinson

Examiner (ID: 8117)

Most Active Art Unit
1746
Art Unit(s)
1792, 1711, 2402, 1746, 2899, 3405, 1743
Total Applications
3621
Issued Applications
3013
Pending Applications
138
Abandoned Applications
470

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 18012090 [patent_doc_number] => 11504364 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-11-22 [patent_title] => Inhibitors of fibroblast activation protein [patent_app_type] => utility [patent_app_number] => 16/724198 [patent_app_country] => US [patent_app_date] => 2019-12-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 6 [patent_no_of_words] => 45483 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16724198 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/724198
Inhibitors of fibroblast activation protein Dec 20, 2019 Issued
Array ( [id] => 16360894 [patent_doc_number] => 20200317645 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-10-08 [patent_title] => CRYSTALLINE FGFR4 INHIBITOR COMPOUND AND USES THEREOF [patent_app_type] => utility [patent_app_number] => 16/722838 [patent_app_country] => US [patent_app_date] => 2019-12-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10250 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16722838 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/722838
Crystalline FGFR4 inhibitor compound and uses thereof Dec 19, 2019 Issued
Array ( [id] => 17378072 [patent_doc_number] => 11236069 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-02-01 [patent_title] => KIF18A inhibitors [patent_app_type] => utility [patent_app_number] => 16/724119 [patent_app_country] => US [patent_app_date] => 2019-12-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 35366 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 207 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16724119 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/724119
KIF18A inhibitors Dec 19, 2019 Issued
Array ( [id] => 16450956 [patent_doc_number] => 20200360382 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-11-19 [patent_title] => 3-(SUBSTITUTED-4-OXOQUINAZOLIN-3(4H)-YL)-3-DEUTERO-PIPERIDINE-2,6-DIONE DERIVATIVES AND COMPOSITIONS COMPRISING AND METHODS OF USING THE SAME [patent_app_type] => utility [patent_app_number] => 16/716662 [patent_app_country] => US [patent_app_date] => 2019-12-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22505 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -12 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16716662 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/716662
3-(substituted-4-oxoquinazolin-3(4 Dec 16, 2019 Issued
Array ( [id] => 16252080 [patent_doc_number] => 20200261454 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-08-20 [patent_title] => DIHYDROPYRIDOPHTHALAZINONE INHIBITORS OF POLY(ADP-RIBOSE)POLYMERASE (PARP) [patent_app_type] => utility [patent_app_number] => 16/714474 [patent_app_country] => US [patent_app_date] => 2019-12-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 72425 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -14 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16714474 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/714474
Dihydropyridophthalazinone inhibitors of poly(ADP-ribose)polymerase (PARP) Dec 12, 2019 Issued
Array ( [id] => 17904277 [patent_doc_number] => 11458109 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-10-04 [patent_title] => Treatment of 22Q11.2 deletion syndrome with cannabidiol [patent_app_type] => utility [patent_app_number] => 16/712066 [patent_app_country] => US [patent_app_date] => 2019-12-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 4738 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 45 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16712066 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/712066
Treatment of 22Q11.2 deletion syndrome with cannabidiol Dec 11, 2019 Issued
Array ( [id] => 17458689 [patent_doc_number] => 20220071993 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-03-10 [patent_title] => A VILAZODONE SOLID DISPERSION AND PREPARATION METHOD THEREOF [patent_app_type] => utility [patent_app_number] => 17/311784 [patent_app_country] => US [patent_app_date] => 2019-12-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12223 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -28 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17311784 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/311784
A VILAZODONE SOLID DISPERSION AND PREPARATION METHOD THEREOF Dec 10, 2019 Pending
Array ( [id] => 16452527 [patent_doc_number] => 20200361953 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-11-19 [patent_title] => PRODUCTION METHOD OF THIENOPYRIMIDINE DERIVATIVE [patent_app_type] => utility [patent_app_number] => 16/710390 [patent_app_country] => US [patent_app_date] => 2019-12-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10468 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => 0 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16710390 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/710390
Production method of thienopyrimidine derivative Dec 10, 2019 Issued
Array ( [id] => 16435621 [patent_doc_number] => 20200352946 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-11-12 [patent_title] => COMPOUNDS FOR THE PREVENTION AND TREATMENT OF CARDIOVASCULAR DISEASES [patent_app_type] => utility [patent_app_number] => 16/707559 [patent_app_country] => US [patent_app_date] => 2019-12-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 43699 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -15 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16707559 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/707559
COMPOUNDS FOR THE PREVENTION AND TREATMENT OF CARDIOVASCULAR DISEASES Dec 8, 2019 Abandoned
Array ( [id] => 17532288 [patent_doc_number] => 20220110897 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-04-14 [patent_title] => COMPOSITIONS AND METHODS FOR TREATING BIOFILMS [patent_app_type] => utility [patent_app_number] => 17/295656 [patent_app_country] => US [patent_app_date] => 2019-12-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 47084 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17295656 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/295656
Compositions and methods for treating biofilms Dec 2, 2019 Issued
Array ( [id] => 16072181 [patent_doc_number] => 20200190077 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-06-18 [patent_title] => NEUROPROTECTIVE HYDRAZIDES [patent_app_type] => utility [patent_app_number] => 16/699684 [patent_app_country] => US [patent_app_date] => 2019-12-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2807 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -6 [patent_words_short_claim] => 225 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16699684 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/699684
NEUROPROTECTIVE HYDRAZIDES Nov 30, 2019 Abandoned
Array ( [id] => 16444829 [patent_doc_number] => 10836741 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2020-11-17 [patent_title] => Quinazolinones and azaquinazolinones as ubiquitin-specific protease 7 inhibitors [patent_app_type] => utility [patent_app_number] => 16/694500 [patent_app_country] => US [patent_app_date] => 2019-11-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 27227 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 606 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16694500 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/694500
Quinazolinones and azaquinazolinones as ubiquitin-specific protease 7 inhibitors Nov 24, 2019 Issued
Array ( [id] => 15996273 [patent_doc_number] => 20200174007 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-06-04 [patent_title] => REAGENTS FOR QUANTITATIVE MASS SPECTROMETRY [patent_app_type] => utility [patent_app_number] => 16/692762 [patent_app_country] => US [patent_app_date] => 2019-11-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 25088 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -7 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16692762 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/692762
Reagents for quantitative mass spectrometry Nov 21, 2019 Issued
Array ( [id] => 17996632 [patent_doc_number] => 11497718 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-11-15 [patent_title] => Use of tapinarof for the treatment of atopic dermatitis [patent_app_type] => utility [patent_app_number] => 16/682485 [patent_app_country] => US [patent_app_date] => 2019-11-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 27219 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 60 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16682485 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/682485
Use of tapinarof for the treatment of atopic dermatitis Nov 12, 2019 Issued
Array ( [id] => 17996632 [patent_doc_number] => 11497718 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-11-15 [patent_title] => Use of tapinarof for the treatment of atopic dermatitis [patent_app_type] => utility [patent_app_number] => 16/682485 [patent_app_country] => US [patent_app_date] => 2019-11-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 27219 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 60 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16682485 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/682485
Use of tapinarof for the treatment of atopic dermatitis Nov 12, 2019 Issued
Array ( [id] => 16297696 [patent_doc_number] => 20200283419 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-09-10 [patent_title] => POLYMORPHS OF SELINEXOR [patent_app_type] => utility [patent_app_number] => 16/679630 [patent_app_country] => US [patent_app_date] => 2019-11-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 32895 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -13 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16679630 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/679630
Polymorphs of selinexor Nov 10, 2019 Issued
Array ( [id] => 15895417 [patent_doc_number] => 20200147227 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-05-14 [patent_title] => DRUG-BOUND COMPOUND AND USE THEREOF [patent_app_type] => utility [patent_app_number] => 16/677212 [patent_app_country] => US [patent_app_date] => 2019-11-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5671 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -12 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16677212 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/677212
Drug-bound compound and use thereof Nov 6, 2019 Issued
Array ( [id] => 15862815 [patent_doc_number] => 20200138811 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-05-07 [patent_title] => Chemical Compounds [patent_app_type] => utility [patent_app_number] => 16/673014 [patent_app_country] => US [patent_app_date] => 2019-11-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14356 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -5 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16673014 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/673014
Sulfonamide derivatives as JAK inhibitors Nov 3, 2019 Issued
Array ( [id] => 19762130 [patent_doc_number] => 12220400 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2025-02-11 [patent_title] => Amino acid compositions and methods for treating cystic fibrosis [patent_app_type] => utility [patent_app_number] => 17/289374 [patent_app_country] => US [patent_app_date] => 2019-10-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 25 [patent_no_of_words] => 28946 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 85 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17289374 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/289374
Amino acid compositions and methods for treating cystic fibrosis Oct 29, 2019 Issued
Array ( [id] => 17118723 [patent_doc_number] => 11129832 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2021-09-28 [patent_title] => Biheteroaryl compounds and uses thereof [patent_app_type] => utility [patent_app_number] => 16/666273 [patent_app_country] => US [patent_app_date] => 2019-10-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 71724 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16666273 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/666273
Biheteroaryl compounds and uses thereof Oct 27, 2019 Issued
Menu